Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Department of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France.
Nat Commun. 2024 Sep 30;15(1):8436. doi: 10.1038/s41467-024-52763-y.
Although rare genetic conditions are mostly caused by DNA sequence alterations that functionally disrupt individual genes, large-scale studies using genome sequencing have started to unmask additional complexity. Understanding how combinations of variants in different genes shape human phenotypes is expected to provide important insights into the clinical and genetic heterogeneity of rare disorders. Here, we use albinism, an archetypal rare condition associated with hypopigmentation, as an exemplar for the study of genetic interactions. We analyse data from the Genomics England 100,000 Genomes Project alongside a cohort of 1120 individuals with albinism, and investigate the effect of dual heterozygosity for the combination of two established albinism-related variants: TYR:c.1205 G > A (p.Arg402Gln) [rs1126809] and OCA2:c.1327 G > A (p.Val443Ile) [rs74653330]. As each of these changes alone is insufficient to cause disease when present in the heterozygous state, we sought evidence of synergistic effects. We show that, when both variants are present, the probability of receiving a diagnosis of albinism is significantly increased (odds ratio 12.8; 95% confidence interval 6.0 - 24.7; p-value 2.1 ×10). Further analyses in an independent cohort, the UK Biobank, support this finding and highlight that heterozygosity for the TYR:c.1205 G > A and OCA2:c.1327 G > A variant combination is associated with statistically significant alterations in visual acuity and central retinal thickness (traits that are considered albinism endophenotypes). The approach discussed in this report opens up new avenues for the investigation of oligogenic patterns in apparently Mendelian disorders.
虽然罕见的遗传疾病主要是由功能上破坏单个基因的 DNA 序列改变引起的,但使用基因组测序的大规模研究已经开始揭示更多的复杂性。了解不同基因中的变体组合如何塑造人类表型,有望为罕见疾病的临床和遗传异质性提供重要的见解。在这里,我们以白化病为例,研究遗传相互作用。白化病是一种与色素减退相关的典型罕见疾病。我们分析了英国基因组工程 10 万基因组计划的数据,以及 1120 名白化病患者的队列,并研究了两种已建立的白化病相关变体的双重杂合性的影响:TYR:c.1205G > A(p.Arg402Gln)[rs1126809]和 OCA2:c.1327G > A(p.Val443Ile)[rs74653330]。由于这两种变化中的每一种在杂合状态下单独存在时都不足以导致疾病,因此我们寻求协同作用的证据。我们表明,当两种变体都存在时,白化病的诊断概率显著增加(优势比 12.8;95%置信区间 6.0-24.7;p 值 2.1×10)。在英国生物银行的一个独立队列中的进一步分析支持了这一发现,并强调了 TYR:c.1205G > A 和 OCA2:c.1327G > A 变体组合的杂合性与视力和中央视网膜厚度的统计学显著改变相关(这些特征被认为是白化病的表型)。本报告中讨论的方法为研究明显孟德尔疾病中的寡基因模式开辟了新途径。